This HTML5 document contains 193 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n5http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q30408170
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en 2014 επιστημονικό άρθρο article científic 2014年論文 мақолаи илмӣ mokslinis straipsnis videnskabelig artikel (udgivet 2014) บทความทางวิทยาศาสตร์ artikull shkencor naučni članak bilimsel makale wissenschaftlicher Artikel tudományos cikk 2014年論文 2014年論文 article scientifique (publié 2014) artigo científico bài báo khoa học سائنسی مضمون مقالهٔ علمی tieteellinen artikkeli 2014年论文 2014年の論文 наукова стаття, опублікована в січні 2014 2014 թվականի հունվարին հրատարակված գիտական հոդված מאמר מדעי artigo científico (publicado na 2014) научная статья مقالة علمية (نشرت في 6-1-2014) 2014年论文 2014年論文 wetenschappelijk artikel vedecký článok artykuł naukowy vitenskapelig artikkel artikulong pang-agham научни чланак artículo científico publicado en 2014 2014 թուականի Յունուարին հրատարակուած գիտական յօդուած 2014年论文 2014 nî lūn-bûn 2014年论文 2014年論文 vitskapeleg artikkel artigo científico (publicado na 2014) article scientific teaduslik artikkel научни чланак scientific article სამეცნიერო სტატია 2014年论文 мақолаи илмӣ articol științific vetenskaplig artikel ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2014년 논문 2014年论文 vědecký článek scienca artikolo articolo scientifico научна статия
p:P577
wds:Q30408170-D5D96FD5-174A-499D-A341-81301D5B5DFF
wdt:P577
2014-01-06T00:00:00Z
p:P407
wds:Q30408170-145F6386-2308-4DD2-B048-FFBF09CC6CFC
wdt:P407
wd:Q1860
p:P2860
wds:Q30408170-13F53308-993B-486B-BC9B-44528CFA4A78 wds:Q30408170-156F5658-DFD8-429C-8C96-7A7AC735692A wds:Q30408170-2ECA6D3A-1D62-43D8-83E0-899A067B1975 wds:Q30408170-3AC0EC69-E0BD-44DA-97F1-19DB251F6822 wds:Q30408170-00B7ECEC-93CB-43A9-A426-53229ACD18D2 wds:Q30408170-0EE167D1-0630-41B1-AA8A-040BA9F42EB0 wds:Q30408170-5A18BF3F-B572-4DC1-9541-788715D4E1B2 wds:Q30408170-5F9152E2-1F92-4750-ABBD-E84C2033682F wds:Q30408170-7873E596-3554-4334-9D88-420D4F202DFB wds:Q30408170-7C6C9794-E4AB-43AE-9F60-43CF032AD40C wds:Q30408170-3C36C96A-7CBC-4566-888F-0D3355438E8C wds:Q30408170-406B39C2-7711-4A85-91E3-00DDE28DCEF9 wds:Q30408170-54555311-2BA6-4A03-87A5-DC6565104FCF wds:Q30408170-FC05CEC5-1226-4991-814A-9057BFC15057 wds:Q30408170-A09138B6-E41F-485C-A8F3-E23064B679F2 wds:Q30408170-A48B724F-D1B6-4DBF-B848-02EFC306633F wds:Q30408170-A7C4ED76-337A-4A17-81BE-58791C82CFAA wds:Q30408170-AA538012-0984-493B-8A82-2CE6367501E6 wds:Q30408170-858CEABF-D0ED-456F-923A-70933E4EA8B9 wds:Q30408170-8D2812F9-F1D4-4062-AE76-099311938000 wds:Q30408170-93700F6E-92B5-4F78-B62B-2BF2629AFA8A wds:Q30408170-95C90F2F-8688-4F93-94B1-E0ACD8565F10 wds:Q30408170-E855F365-CFDD-421C-A544-F41ABA7CDC96 wds:Q30408170-E990E855-6DB9-46C2-9A93-61D836486E29 wds:Q30408170-EF59B799-EBE7-488A-ACF5-473AC4238D0E wds:Q30408170-EF99B676-45A8-423D-9894-A5600813F456 wds:Q30408170-F8DD11BE-FFD2-4BE2-86D8-45C9C59FAD4A wds:Q30408170-C0302D6B-4F0B-40C9-8E64-0C4A994B3E20 wds:Q30408170-C577146F-4774-4B58-BCE4-85A63F6114C8 wds:Q30408170-CE195903-D382-4177-A27D-8F1CFAB694B3 wds:Q30408170-D092EB0A-89A6-4131-A0C7-B4D69A71A58A
wdt:P2860
wd:Q33685983 wd:Q53346033 wd:Q33371734 wd:Q32012814 wd:Q40354475 wd:Q47405638 wd:Q73045419 wd:Q77321070 wd:Q73665855 wd:Q77321076 wd:Q77321080 wd:Q47253781 wd:Q28282755 wd:Q46100154 wd:Q32034427 wd:Q50497363 wd:Q36597012 wd:Q33877024 wd:Q28248823 wd:Q36291599 wd:Q61889942 wd:Q72838287 wd:Q83737796 wd:Q40380436 wd:Q43614988 wd:Q51728958 wd:Q36626434 wd:Q41213138 wd:Q41530059 wd:Q73675166 wd:Q27860574
p:P2093
wds:Q30408170-4F01ED66-4ABB-45B1-AEC1-603715DF29BC wds:Q30408170-3D7B02B7-75EA-4A3A-A1F7-7FB1DA36B9BC wds:Q30408170-247D6665-C599-41C5-B85E-63F25699E052 wds:Q30408170-2AFF5A37-7AAA-41E0-B7E4-5A8B98C8FDE6 wds:Q30408170-046E9BF6-6AEF-4773-9303-50762F4D06A4 wds:Q30408170-F1677BE8-508B-4306-BC80-92E1323A443D wds:Q30408170-A1C27F61-F6AD-4109-BA6A-2D0D1C4B6A66 wds:Q30408170-9F9E6D14-BE92-4AD3-8439-64B2B7F469BB wds:Q30408170-92388FFC-616E-45B5-A47C-1D3313D645C0 wds:Q30408170-8B944B5A-0EBD-4BF7-9B1D-BAB9E2E37B6F
wdt:P2093
Nicola M Spirtos Peter S Craighead Carolyn Muller Paul A DiSilvestro Krishnasu S Tewari Yi-Chun Lee Shamshad Ali Walter H Gajewski Joseph A Lucci Margaret M Steinhoff
rdfs:label
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study. Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study. Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study.
skos:prefLabel
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study. Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study. Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study.
schema:name
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study. Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study. Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study.
p:P50
wds:Q30408170-EB6A3778-3534-4B46-8BF9-6F7D7ABEA351 wds:Q30408170-64B7B8A7-B11F-4770-BEA5-8BFF32FE878A
wdt:P50
wd:Q39381089 wd:Q107013145
p:P1476
wds:Q30408170-3C0130FD-8895-4884-B6A4-A36A47BD7FC3
wdt:P1476
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study
p:P304
wds:Q30408170-9159DCA6-4DBD-4BA6-A4CC-B5AC6EA0456F
wdt:P304
458-464
p:P31
wds:Q30408170-CAD7BF07-7F14-4CDD-B7C5-EED029E56B29
wdt:P31
wd:Q13442814
p:P2283
wds:Q30408170-99E66249-A48E-44C3-BEE2-8D670A0CC010
wdt:P2283
wd:Q1231081
p:P921
wds:Q30408170-4A72EF37-6DFB-4484-AD34-F2F8FBAF4061 wds:Q30408170-564A7759-6937-4FBA-9A07-C826D2DE5ED2 wds:Q30408170-C6E3BCB8-30E1-4C66-9779-0C91B026D68D wds:Q30408170-EACC2FEC-E6B1-46A3-A9FE-DB5393C47B2A
wdt:P921
wd:Q3529346 wd:Q5625186 wd:Q412415 wd:Q42824827
p:P698
wds:Q30408170-5E1C83CB-E7AA-4BD8-A856-93C4BB47D333
wdtn:P698
n11:24395863
wdt:P698
24395863
p:P1433
wds:Q30408170-AF1F1538-8218-43A7-89E6-5F6D3962F718
wdt:P1433
wd:Q400292
p:P433
wds:Q30408170-596DCB10-1A8C-482F-B325-34E05A1232C1
p:P478
wds:Q30408170-2431D25E-3784-4659-9D99-32ED08412B42
wdt:P433
5
wdt:P478
32
p:P356
wds:Q30408170-B716B19E-8A93-43B2-913B-DE30C103BD59
wdtn:P356
n5:JCO.2013.51.4265
wdt:P356
10.1200/JCO.2013.51.4265
p:P5875
wds:Q30408170-9F08A75D-943C-4F8B-9188-BAA5FD6905AE
wdt:P5875
259608236
p:P932
wds:Q30408170-74A8D53A-311F-42E7-B2BF-99326E752267
wdt:P932
3912330